Management of patients with ovarian cancer in the COVID-19 era

J Surg Oncol. 2020 Aug;122(2):122-123. doi: 10.1002/jso.26057. Epub 2020 May 31.

Abstract

At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.

Keywords: COVID-19; SARS-CoV; chemotherapy; ovarian cancer; surgery.

MeSH terms

  • Betacoronavirus / isolation & purification
  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / transmission
  • Female
  • Gynecologic Surgical Procedures / methods
  • Gynecologic Surgical Procedures / standards
  • Humans
  • Infection Control / methods
  • Infection Control / standards
  • Infectious Disease Transmission, Patient-to-Professional / prevention & control
  • Laparoscopy / methods
  • Laparoscopy / standards
  • Ovarian Neoplasms / surgery*
  • Ovarian Neoplasms / virology
  • Pandemics / prevention & control*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / transmission
  • SARS-CoV-2
  • Surgical Oncology / methods*
  • Surgical Oncology / standards